Edison, NJ, United States of America

Wansheng Liu

This inventor holds 3 USPTO granted patents. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2007-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wansheng Liu. Retrieved from https://idiyas.com/inventor/wansheng-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Wansheng Liu: Innovator in Azaindole Derivatives

Introduction

Wansheng Liu is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of antiviral compounds, holding a total of 3 patents. His work focuses on the preparation of azaindole derivatives, which have important applications in medicine.

Latest Patents

Wansheng Liu's latest patents include a method of preparation of azaindole derivatives. This innovative method is designed for the synthesis of azaindole compounds that are intended for antiviral use. The formula developed by Liu represents a significant advancement in the field of antiviral research.

Career Highlights

Wansheng Liu is currently employed at Bristol-Myers Squibb Company, a leading biopharmaceutical company. His role involves extensive research and development in the area of antiviral medications. Liu's expertise and innovative approaches have contributed to the company's mission of discovering and developing innovative medicines.

Collaborations

Throughout his career, Wansheng Liu has collaborated with several talented professionals, including Sunil S Patel and Nicolas Cuniere. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Wansheng Liu is a distinguished inventor whose work in the preparation of azaindole derivatives has the potential to impact antiviral therapies significantly. His contributions to Bristol-Myers Squibb Company and collaborations with other professionals highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…